Contrast-enhanced ultrasound in diagnosing liver malignancy

I Zuber-Jerger1, D Schacherer, M Woenckhaus

  • 1Department of Internal Medicine I, University of Regensburg, Regensburg, Germany. ina.zuber-jerger@klinik.uni-regensburg.de

Summary

Contrast-enhanced ultrasound reveals that diminishing contrast agent in the late phase is a key indicator for diagnosing malignant liver lesions. This sign offers high accuracy in differentiating cancerous from benign tumors.